ACAD
42.22
+4.15
+10.90%
AEMD
7.67
-0.18
-2.29%
APRI
1.62
-0.07
-4.1361%
ARNA
2.78
+0.08
+2.96%
ATEC
0.588
+0.018
+3.158%
CNAT
3.99
+0.02
+0.50%
CRXM
0.35
0.00
0.00%
CYTX
0.365
+0.012
+3.3682%
DXCM
89.02
-0.35
-0.39%
GNMK
9.73
-0.08
-0.82%
HALO
17.77
+0.23
+1.31%
ILMN
197.89
-0.22
-0.11%
INNV
0.11
0.00
+0.09%
INO
7.22
-0.01
-0.14%
ISCO
3.6
-0.1
-2.70%
ISIS
52.13
+0.38
+0.73%
LGND
91.21
-1.21
-1.31%
LPTN
0.24
-0.001
-0.5797%
MBVX
1.52
-0.16
-9.79%
MEIP
1.901
+0.041
+2.204%
MNOV
3.27
+0.13
+4.14%
MRTX
27
-0.84
-3.02%
MSTX
0.49
+0.01
+2.92%
NBIX
50.07
+0.44
+0.8864%
NUVA
52.38
+0.23
+0.44%
ONCS
5.65
-0.11
-1.91%
ONVO
2.7
+0.06
+2.27%
OREX
2.815
+0.07
+2.550%
OTIC
22.01
-0.38
-1.70%
QDEL
21.185
-0.265
-1.235%
RCPT
231.96
0.00
0.00%
RGLS
9.13
-0.11
-1.19%
RMD
51.98
+0.07
+0.13%
SCIE
0.014
0.00
0.00%
SPHS
0.843
-0.007
-0.824%
SRNE
13.08
-0.24
-1.80%
TROV
6.12
-0.21
-3.32%
VICL
0.61
+0.01
+1.58%
VOLC
18
0.00
0.00%
ZGNX
20.34
-0.16
-0.78%
ACAD
42.22
+4.15
+10.90%
AEMD
7.67
-0.18
-2.29%
APRI
1.62
-0.07
-4.1361%
ARNA
2.78
+0.08
+2.96%
ATEC
0.588
+0.018
+3.158%
CNAT
3.99
+0.02
+0.50%
CRXM
0.35
0.00
0.00%
CYTX
0.365
+0.012
+3.3682%
DXCM
89.02
-0.35
-0.39%
GNMK
9.73
-0.08
-0.82%
HALO
17.77
+0.23
+1.31%
ILMN
197.89
-0.22
-0.11%
INNV
0.11
0.00
+0.09%
INO
7.22
-0.01
-0.14%
ISCO
3.6
-0.1
-2.70%
ISIS
52.13
+0.38
+0.73%
LGND
91.21
-1.21
-1.31%
LPTN
0.24
-0.001
-0.5797%
MBVX
1.52
-0.16
-9.79%
MEIP
1.901
+0.041
+2.204%
MNOV
3.27
+0.13
+4.14%
MRTX
27
-0.84
-3.02%
MSTX
0.49
+0.01
+2.92%
NBIX
50.07
+0.44
+0.8864%
NUVA
52.38
+0.23
+0.44%
ONCS
5.65
-0.11
-1.91%
ONVO
2.7
+0.06
+2.27%
OREX
2.815
+0.07
+2.550%
OTIC
22.01
-0.38
-1.70%
QDEL
21.185
-0.265
-1.235%
RCPT
231.96
0.00
0.00%
RGLS
9.13
-0.11
-1.19%
RMD
51.98
+0.07
+0.13%
SCIE
0.014
0.00
0.00%
SPHS
0.843
-0.007
-0.824%
SRNE
13.08
-0.24
-1.80%
TROV
6.12
-0.21
-3.32%
VICL
0.61
+0.01
+1.58%
VOLC
18
0.00
0.00%
ZGNX
20.34
-0.16
-0.78%
Home » Events, SDBN Blog, SDBN Events

SDBN August Event: The Transformation of the Biotech Business Model

Submitted by on August 11, 2009 – 5:10 pm

Our August event will feature an interactive panel in which we’ll discuss the areas you are interested in hearing about: Green technology, Translational Research/Medicine, and Drug Development.

Transformation of Biotech Panel Members:

* Aileen Alvarado-Swaisgood, President, Molecular Alliance (moderator)
* Nigel Beeley, CEO, ENRQI
* Roy Cosan, Director, Strategic Planning & Alliance Management, External Research and Early Development, Johnson & Johnson PRD
* Ali Esteghlalian, Product Manager, Industrial Enzymes & Principal Scientist, Enzyme Applications, Verenium
* Gary Firestein, Professor of Medicine, Chief, Division of Rheumatology Allergy & Immunology, Dean, Translational Medicine, UCSD
* Bruce Steel, Chief Business Officer, Anaphore

[[Click Here For More Information]]

Leave a comment!

Add your comment below, or trackback from your own site. You can also Comments Feed via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:

<a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> 

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.


9 × three =